View in EDS

Licofelone, a potent COX/5-LOX inhibitor and a novel option for treatment of neurological disorders.

Saved in:
Bibliographic Details
Title: Licofelone, a potent COX/5-LOX inhibitor and a novel option for treatment of neurological disorders.
Authors: Razavi SM; Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Khayatan D; Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Arab ZN; Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Momtaz S; Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Tehran, Iran; Department of Toxicology and Pharmacology, School of Pharmacy, and Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran; GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Zare K; School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran., Jafari RM; Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran., Dehpour AR; Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: dehpour@yahoo.com., Abdolghaffari AH; Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Tehran, Iran; Department of Toxicology and Pharmacology, School of Pharmacy, and Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran; GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran. Electronic address: amirhosein172@hotmail.com.
Source: Prostaglandins & other lipid mediators [Prostaglandins Other Lipid Mediat] 2021 Dec; Vol. 157, pp. 106587. Date of Electronic Publication: 2021 Sep 10.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 9808648 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-8823 (Print) Linking ISSN: 10988823 NLM ISO Abbreviation: Prostaglandins Other Lipid Mediat Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-8823
DOI:10.1016/j.prostaglandins.2021.106587